Trial intelligence / Profile preview

12-week randomized double-blind comparison of ankle edema with Lodien vs Norvasc in female essential hypertension

KCT0000450Phase 4Completed

Sponsor
Hanlim Pharm
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amlodipine in essential hypertension, sponsored by Hanlim Pharm. Started Jan 2010; status: completed.

02

Drugs

amlodipine
03

Conditions

essential hypertension

Beyond the preview

Go deeper on KCT0000450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call